Vestmark Advisory Solutions’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$440K Buy
+4,181
New +$389K ﹤0.01% 1320
2021
Q2
– Sell
-2,566
Closed -$285K – 784
2021
Q1
$285K Buy
2,566
+98
+4% +$12.1K 0.03% 609
2020
Q4
$293K Sell
2,468
-50
-2% -$5.38K 0.03% 471
2020
Q3
$220K Buy
+2,518
New +$220K 0.03% 512

Other funds holding HAE

Vestmark Advisory Solutions's HAE Position: Q3 2026 in Review

Vestmark Advisory Solutions opened a new position in Haemonetics (HAE) in Q3 2026: 4,181 shares worth $440K. The stake represents ﹤0.01% of the portfolio and ranks #1320 among its holdings. This is a return to the name: Vestmark Advisory Solutions previously reported a position in HAE as recently as Q1 2021.

Vestmark Advisory Solutions first reported a position in HAE in Q3 2020 and has held it in 4 quarters since. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Vestmark Advisory Solutions held 4,181 shares of Haemonetics worth $440K as of Q3 2026.
  • Haemonetics was a new Vestmark Advisory Solutions position in Q3 2026.
  • Haemonetics made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q3 2026, its #1320 holding.
  • Vestmark Advisory Solutions first reported a position in Haemonetics in Q3 2020 and has held it in 4 quarters since.
  • 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.